Scotland

Kyowa Kirin’s Poteligeo provides progression-free survival in CTCL trial

Kyowa Kirin has reported that the MAVORIC trial of Poteligeo (mogamulizumab) in patients with mycosis fungoides (MF) and Sézary syndrome…

Coronavirus: COVID-19 UK outbreak, measures and impact

Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates Coronavirus FAQs Follow the latest updates on coronavirus…

[ajax_load_more post_type="post" taxonomy="sector" taxonomy_terms="scotland" taxonomy_operator="IN" images_loaded="true" posts_per_page="5" offset="16" pause="true" scroll="false" button_label="View More"]